We are monitoring the impact of COVID-19 on Asia-Pacific Renal Disease Therapeutics Market Get in touch with us for detailed analysis Know More
Pulished Date February, 2020
ID: 1220
Share on
Share on

Asia-Pacific Renal Disease Therapeutics Market By Application (Kidney Stone Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Kidney Disease, Hypertension, Diabetes, Anaemia), By Treatment Devices (Dialysis Equipment, Renal Denervation Devices, Wearable Artificial Kidney Device, Distal Embolic Protection Devices) And By Region - Industry Analysis, Size, Share, Growth, Trends, And Forecasts (2018-2023)

Pulished: February, 2020
ID: 1220
Pages: 145

Asia-Pacific is predicted to account for the highest CAGR over the forecast period owing to increasing aging population.

Because of the high incidence of Diabetic cases and high blood pressure, improper functioning of the kidneys and associated renal system over a longer period of time leads to renal diseases. Kidneys have numerous functions, such as a balance of water and minerals, such as sodium, and phosphorus in the blood, remove waste products from the blood after digestion, muscle activity, and exposure to chemicals or medications. If any form of damage to the kidney occurs, they ultimately lose their vital function, which is fatal.

Asia-Pacific Renal Disease Therapeutics Market was worth $ x.xx billion in 2018 and estimated to reach $ x.xx billion by the end of 2023 with a CAGR of x.xx %.

Growing aging population, increasing number of individuals with insurance due to the Affordable Care Act, Increasing Diabetic Population, growing awareness of both acute and chronic kidney disease, and growing demand for the advanced diagnostics and therapeutics for the disease are the major factors that are driving the growth of Asia-Pacific Renal disease Therapeutics Market. The factors that are hindering the growth of the market are disparities of Renal Transplant Therapy, expiring of patents of some of the branded drugs for the late stage CKD and changing reimbursement scenario in some of the major countries, Negative Societal Effects.

The Asia-Pacific Renal Disease Therapeutics market is segmented based on the Application and treatment. Application mode is segmented into Kidney Stone Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Kidney Disease, Hypertension, Diabetes, and Anaemia. The treatment segment is further categorized into Dialysis Equipment, Renal Denervation devices, Wearable artificial kidney device, and distal embolic protection devices. On the basis of geography, the Asia-Pacific Renal Disease Therapeutics market is analyzed under various regions namely China, Japan, India, South Korea and Australia.

Key players operating in Asia-Pacific Renal disease Therapeutics market are Amgen Inc., Merck & Co., Inc., Bristol-Myers Squibb Company, Hoffmann-La Roche Inc., Shire Inc., Fresenius Medical Care, Baxter International, Davita Healthcare Partners.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Application                 

                                5.1.1 Introduction           

                                5.1.2 Kidney Stone Disease         

                                5.1.3 End-Stage Kidney Disease

                                5.1.4 Kidney Failure        

                                5.1.5 Chronic Kidney Disease     

                                5.1.6 Hypertension        

                                5.1.7 Diabetes  

                                5.1.8 Anaemia  

                                5.1.4 Y-o-Y Growth Analysis, By Application         

                                5.1.5 Market Attractiveness Analysis, By Application        

                                5.1.6 Market Share Analysis, By Application         

                5.2 Treatment devices                  

                                5.2.1 Introduction           

                                5.2.2 Dialysis Equipment              

                                5.2.3 Renal Denervation devices

                                5.2.4 Wearable artificial kidney device   

                                5.2.5 distal embolic protection devices  

                                5.2.6 Y-o-Y Growth Analysis, By Treatment devices           

                                5.2.7 Market Attractiveness Analysis, By Treatment devices         

                                5.2.8 Market Share Analysis, By Treatment devices          

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Application

                                                6.1.3.3 By Treatment Devices

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Application

                                                6.1.4.3 By Treatment devices

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Application

                                                6.1.5.3 By Treatmentr Devices

                6.2 China                            

                6.3 India                              

                6.4 Japan                            

                6.5 South Korea               

                6.6 Australia                      

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Amgen Inc.                 

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Merck & Co., Inc.                     

                8.3 Bristol-Myers Squibb Company                          

                8.4 Hoffmann-La Roche Inc                         

                8.5 Shire Inc.                     

                8.6 Fresenius Medical Care                         

                8.7 Baxter International               

                8.8 Davita Healthcare Partners                  

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. Asia-Pacific Diabetes Care Devices Market By Application, From 2018-2023 ( USD Million )
  2. Asia-Pacific Kidney Stone Disease Market By Region, From 2018-2023 ( USD Million )
  3. Asia-Pacific End-Stage Kidney Disease Market By Region, From 2018-2023 ( USD Million )
  4. Asia-Pacific Kidney Failure Market By Region, From 2018-2023 ( USD Million )
  5. Asia-Pacific Chronic Kidney Disease Market By Region, From 2018-2023 ( USD Million )
  6. Asia-Pacific Hypertension Market By Region, From 2018-2023 ( USD Million )
  7. Asia-Pacific Diabetes Market By Region, From 2018-2023 ( USD Million )
  8. Asia-Pacific Anaemia Market By Region, From 2018-2023 ( USD Million )
  9. Asia-Pacific Diabetes Care Devices Market By Treatment Devices, From 2018-2023 ( USD Million )
  10. Asia-Pacific Dialysis Equipment Market By Region, From 2018-2023 ( USD Million )
  11. Asia-Pacific Renal Denervation Devices Market By Region, From 2018-2023 ( USD Million )
  12. Asia-Pacific Wearable Artificial Kidney Device Market By Region, From 2018-2023 ( USD Million )
  13. Asia-Pacific Distal Embolic Protection Devices Market By Region, From 2018-2023 ( USD Million )
  14. Asia-Pacific Distal Embolic Protection Devices Market By Region, From 2018-2023 ( USD Million )
  15. Japan Diabetes Care Devices Market By Application, From 2018-2023 ( USD Million )
  16. Japan Diabetes Care Devices Market By Treatment Devices, From 2018-2023 ( USD Million )
  17. China Diabetes Care Devices Market By Application, From 2018-2023 ( USD Million )
  18. China Diabetes Care Devices Market By Treatment Devices, From 2018-2023 ( USD Million )
  19. India Diabetes Care Devices Market By Application, From 2018-2023 ( USD Million )
  20. India Diabetes Care Devices Market By Treatment Devices, From 2018-2023 ( USD Million )
  21. Australia Diabetes Care Devices Market By Application, From 2018-2023 ( USD Million )
  22. Australia Diabetes Care Devices Market By Treatment Devices, From 2018-2023 ( USD Million )
  23. South Korea Diabetes Care Devices Market By Application, From 2018-2023 ( USD Million )
  24. South Korea Diabetes Care Devices Market By Treatment Devices, From 2018-2023 ( USD Million )

Please wait. . . . Your request is being processed

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample